Image source: The Motley Fool.
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
Q4 2020 Earnings Call
Mar 25, 2021 , 4:30 p.m. ET
Operator
For further details see:
Neoleukin Therapeutics, Inc. (NLTX) Q4 2020 Earnings Call TranscriptImage source: The Motley Fool.
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
Q4 2020 Earnings Call
Mar 25, 2021 , 4:30 p.m. ET
Operator
For further details see:
Neoleukin Therapeutics, Inc. (NLTX) Q4 2020 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Neoleukin Therapeutics Inc. Company Name:
NLTX Stock Symbol:
Market:
SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its B...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Neoleukin Therapeutics Inc. (NLTX) is expected to report $-0.8 for Q3 2023